Artivion | CRY - Los Gastos Financieros De La Deuda

Precio De Mercado
37.04
Cambio Diario
-0.82 -2.17%
Mensual
-6.49%
Anual
53.18%
Q1 Expectativa
35.91




Los Gastos Financieros De La Deuda Cambio Fecha
Abbott USD 42M 2M 2025-12
Accuray USD 2.88M 72K 2024-12
AngioDynamics USD 100K 134K 2025-02
Artivion USD 7.83M 1.22M 2024-03
AtriCure USD 1.33M 17K 2025-09
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Boston Scientific USD 90M 3M 2025-12
Edwards Lifesciences USD 38.6M 1.2M 2025-09
Inogen 1.03M 384K 2025-03
Integra LifeSciences USD 23.67M 953K 2025-12
J&J USD 18M 290M 2025-09
Mesa Laboratories USD 3.02M 180K 2024-09
Orthofix International 5.2M 4.71M 2024-09
Pfizer USD 711M 59M 2025-12
ResMed USD 8.79M 14.55M 2025-09
Stryker USD 157M 46.17B 2025-09
Surmodics USD 884K 5K 2024-09
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
Terumo JPY 463M 445M 2025-12
Trinity Biotech USD 3.33M 50K 2025-09